Authors: Arenaviridae
Sheli R. Radoshitzky
United States Army Medical Research Institute of Infectious Diseases,
Fort Detrick,
Frederick,
Maryland 21702, USA
E-mail: sheli.r.radoshitzky.ctr@mail.mil
Michael J. Buchmeier
Department of Molecular Biology and Biochemistry,
University of California,
Irvine,
California 92697, USA
E-mail: m.buchmeier@uci.edu
Rémi N. Charrel
Unité des Virus Emergents (Aix-Marseille Univ – IRD 190 – Inserm 1207 – IHU Méditerranée Infection),
13385 Marseille CEDEX 05,
France
E-mail: remi.charrel@univ-amu.fr
Christopher S. Clegg
Les Mandinaux, 16450 Le Grand Madieu,
France
Tel: +33-5-45-310686
E-mail: cleggjcs@yahoo.fr
Jean-Paul J. Gonzalez
Georgetown University,
School of Medicine, Department of Microbiology & Immunology,
Division of Biomedical Graduate Research Organization,
Washington, DC 20057, USA
E-mail: jpgonzalez2808@gmail.com
Stephan Günther
Bernhard-Nocht Institute for Tropical Medicine,
WHO Collaborating Centre for Arboviruses and Hemorrhagic Fever Reference and Research,
Department of Virology,
20359 Hamburg, Germany
Tel: +49-40-42818930
E-mail: guenther@bni.uni-hamburg.de
Jussi Hepojoki
University of Helsinki,
Faculty of Medicine, Medicum, Department of Virology,
00014 Helsinki, Finland
&
Institute of Veterinary Pathology,
Vetsuisse Faculty,
University of Zurich,
Zurich, Switzerland
E-mail: jussi.hepojoki@helsinki.fi; jussi.hepojoki@uzh.ch
Jens H. Kuhn
Integrated Research Facility at Fort Detrick,
National Institute of Allergy and Infectious Diseases,
National Institutes of Health,
Fort Detrick,
Frederick, Maryland 21702, USA
Tel: +1-301-531-7245
E-mail: kuhnjens@mail.nih.gov
Igor S. Lukashevich
Department of Pharmacology and Toxicology,
School of Medicine, and the Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases,
University of Louisville,
Louisville,
Kentucky 40202, USA
E-mail: isluka01@louisville.edu
Víctor Romanowski
Instituto de Biotecnología y Biología Molecular, Centro Científico Tecnológico-La Plata,
Facultad de Ciencias Exactas,
Universidad Nacional de La Plata—Consejo Nacional de Investigaciones Científicas y Técnicas,
49 y 115 s/n La Plata, Argentina
E-mail: victor@biol.unlp.edu.ar
Maria S. Salvato
Institute of Human Virology,
University of Maryland School of Medicine,
Baltimore,
Maryland 21201, USA
E-mail: MSalvato@ihv.umaryland.edu
Manuela Sironi
Bioinformatics, Scientific Institute IRCCS E. MEDEA,
23842 Bosisio Parini,
Italy
E-mail: manuela.sironi@BP.LNF.it
Mark D. Stenglein
Department of Microbiology, Immunology and Pathology,
Colorado State University,
Fort Collins,
Colorado 80523, USA
E-mail: Mark.Stenglein@ColoState.edu
Juan Carlos de la Torre*
Arenaviridae Study Group Chair
Department of Immunology and Microbiology IMM-6,
The Scripps Research Institute,
La Jolla, California 92037, USA
E-mail: juanct@scripps.edu
* to whom correspondence should be addressed
The chapter in the Ninth ICTV Report, which served as the template for this chapter, was contributed by Salvato, M.S., Clegg, J.C.S., Buchmeier, M.J., Charrel, R.N., Gonzalez, J.P., Lukashevich, I.S., Peters, C.J. and Romanowski, V.
Disclaimer
This disclaimer has changed for one author (J.H.K.) since the publication of the JGV Profile. This work was supported in part through Laulima Government Solutions, LLC’s prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272201800013C. JHK performed this work as an employee of Tunnell Government Services (TGS), a subcontractor of Laulima Government Solutions, LLC under Contract No. HHSN272201800013C.This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024, Task Order No. 75N91019F00130 (IC). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.